Ipsen[Grants and Funding] - Search Results

Year	Number of Results
2018	4
2019	8
2020	16
2021	21
2022	16
2023	25
2024	16

1

Systemic therapy of advanced hepatocellular carcinoma.

Galle PR, Dufour JF, Peck-Radosavljevic M, Trojan J, Vogel A. Galle PR, et al. Future Oncol. 2021 Apr;17(10):1237-1251. doi: 10.2217/fon-2020-0758. Epub 2020 Dec 14. Future Oncol. 2021. PMID: 33307782 Free article. Review.

2

Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial.

Pignolo RJ, Baujat G, Hsiao EC, Keen R, Wilson A, Packman J, Strahs AL, Grogan DR, Kaplan FS. Pignolo RJ, et al. J Bone Miner Res. 2022 Oct;37(10):1891-1902. doi: 10.1002/jbmr.4655. Epub 2022 Aug 17. J Bone Miner Res. 2022. PMID: 35854638 Free PMC article. Clinical Trial.

3

Use of AbobotulinumtoxinA for Cosmetic Treatments in the Neck, and Middle and Lower Areas of the Face: A Systematic Review.

Galadari H, Galadari I, Smit R, Prygova I, Redaelli A. Galadari H, et al. Toxins (Basel). 2021 Feb 22;13(2):169. doi: 10.3390/toxins13020169. Toxins (Basel). 2021. PMID: 33671800 Free PMC article.

4

NF-κB signaling activation and roles in thyroid cancers: implication of MAP3K14/NIK.

Cormier F, Housni S, Dumont F, Villard M, Cochand-Priollet B, Mercier-Nomé F, Perlemoine K, Bertherat J, Groussin L. Cormier F, et al. Oncogenesis. 2023 Nov 16;12(1):55. doi: 10.1038/s41389-023-00496-w. Oncogenesis. 2023. PMID: 37973791 Free PMC article.

5

The prevalence of silent acromegaly in prolactinomas is very low.

Bona C, Prencipe N, Jaffrain-Rea ML, Carosi G, Lanzi R, Ambrosio MR, Pasquali D, Vettor R, Cannavò S, Ghigo E, Grottoli S. Bona C, et al. J Endocrinol Invest. 2021 Mar;44(3):531-539. doi: 10.1007/s40618-020-01338-x. Epub 2020 Jun 27. J Endocrinol Invest. 2021. PMID: 32594452

6

The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment.

Chan LL, Chan SL. Chan LL, et al. Clin Mol Hepatol. 2023 Oct;29(4):909-923. doi: 10.3350/cmh.2023.0114. Epub 2023 May 25. Clin Mol Hepatol. 2023. PMID: 37226446 Free PMC article. Review.

7

Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors in Korea: Literature Review and Expert Opinion.

Yoo C, Oh CR, Kim ST, Bae WK, Choi HJ, Oh DY, Lee MA, Ryoo BY. Yoo C, et al. Cancer Res Treat. 2021 Apr;53(2):291-300. doi: 10.4143/crt.2020.1233. Epub 2020 Dec 29. Cancer Res Treat. 2021. PMID: 33421978 Free PMC article. Review.

8

Predictors of pituitary tumour behaviour: an analysis from long-term follow-up in 2 tertiary centres.

Lenders NF, Earls PE, Wilkinson AC, Costin M, Hofer M, Shein TT, Harvey RJ, Krishnan G, Picallo M, Pal A, Wass J, McCormack AI. Lenders NF, et al. Eur J Endocrinol. 2023 Jul 20;189(1):106-114. doi: 10.1093/ejendo/lvad079. Eur J Endocrinol. 2023. PMID: 37461224

9

The prime time for management of hepatocellular carcinoma in Hong Kong.

Chan LL, Chan SL. Chan LL, et al. Clin Mol Hepatol. 2023 Apr;29(2):345-348. doi: 10.3350/cmh.2023.0094. Epub 2023 Mar 9. Clin Mol Hepatol. 2023. PMID: 36907571 Free PMC article. No abstract available.

10

CaboCombo: a prospective, phase IV study of first-line cabozantinib + nivolumab for advanced renal cell carcinoma.

Barthélémy P, Dutailly P, Qvick B, Perrot V, Verzoni E. Barthélémy P, et al. Future Oncol. 2024 Apr;20(13):811-819. doi: 10.2217/fon-2023-0353. Epub 2023 Jul 5. Future Oncol. 2024. PMID: 37403652

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

93 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year